基本释义:

胸腺嘧啶二聚体

网络释义

1)CPDs,胸腺嘧啶二聚体

2)EGCG,胸腺嘧啶二聚体（CPDs）

3)cyclobutane dimethylthymine dimer,环丁烷型胸腺嘧啶二聚体

4)Thymus gland,胸腺

5)Thymus,胸腺

6)Thymopentin,胸腺五肽

用法和例句

Aim To investigate the production and removal of cyclobutane pyrimidine dimers (CPDs) after UVB irradiation and the effect of baikal skullcap root, szechwan lovge rhizome and epigallocatechingallate (EGCG) on the irradiation damage in HaCaT cells, and finally, to clarify the probable regulatory mechanisms.

目的观察中波紫外线(UVB)辐射后HaCaT细胞光产物胸腺嘧啶二聚体(cyclobutanepyrimidine dimers,CPDs)的生成和清除情况及3种中药活性成分:黄芩(baikal skullcap root,BSR)、川芎(szechwan lovge rhizome,SLR)和表没食子儿茶素没食子酸酯[(-)-epigallocatechin-3-gallate,EGCG]对该过程的干预情况并探讨上述药物对相关调控分子的作用机制。

Origins of thymus gland innervation in goat;

支配山羊胸腺的神经纤维起源

Objective To study the relationship between pathological changes of thymus gland and clinical features in patients with myasthenia gravis.

目的探讨重症肌无力患者胸腺的病理改变与临床的关系。

Objective To study MRI findings of the thymus gland in adult patients with ocular-muscular type myasthenia gravis (O-MG).

目的　探讨成年人眼肌型重症肌无力 (O -MG)的胸腺影像学变化特点。

Expression of TLR in mouse thymus and potential role in thymocyte development;

TLR在小鼠胸腺中的表达及其在胸腺细胞发育中的可能作用

Immunohistochemical localization of ghrelin in human thymus;

人胸腺内Ghrelin的免疫组织化学定位

Identification of the related proteins in human myasthenia gravis hyperplastic thymus tissues;

人增生型胸腺组织中重症肌无力相关蛋白鉴定

Preparation and characterization of Thymopentin loaded trimethyl chitosan submicron;

胸腺五肽三甲基壳聚糖口服亚微粒的制备及有关性质

Preparation and quality control of thymopentin nasal spray;

胸腺五肽鼻喷雾剂的研制

Preparation and physical characterization of polylactic-co-glycolic acid nanoparticles loaded with thymopentin for oral administration;

口服胸腺五肽乳酸-羟基乙酸共聚物纳米粒的制备及物理性质考察